Why Switzerland Works for Biotech / Life Sciences
Startup ecosystem quality (100/100) is a key reason Switzerland ranks well for Biotech / Life Sciences. 12 unicorns have originated here, signalling institutional knowledge about building and scaling companies. Talent pool quality scores 85/100, and average senior developer salaries run $160K/year. Sector specializations relevant to Biotech / Life Sciences include: fintech, deeptech, blockchain.
Operational ease (88/100) makes Switzerland practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated easy. Company formation takes approximately 5 days at a cost of around $4K, with annual compliance costs around $5K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated strong, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.
Funding access (85/100) is a standout for Switzerland Biotech / Life Sciences companies. The local market has 80 active VC funds, with average seed checks of $1.5M. Government grant programs include Innosuisse Innovation Projects ($500K) and Swiss Startup Invest ($250K). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.